Annual Operating Expenses
$62.41 M
+$26.00 M+71.40%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual total operating expenses is $62.41 million, with the most recent change of +$26.00 million (+71.40%) on December 31, 2023.
- During the last 3 years, KYTX annual operating expenses has risen by +$30.40 million (+95.01%).
- KYTX annual operating expenses is now at all-time high.
Performance
KYTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$38.77 M
+$5.33 M+15.96%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly total operating expenses is $38.77 million, with the most recent change of +$5.33 million (+15.96%) on September 30, 2024.
- Over the past year, KYTX quarterly operating expenses has increased by +$17.39 million (+81.36%).
- KYTX quarterly operating expenses is now at all-time high.
Performance
KYTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
KYTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.4% | +81.4% |
| 3 y3 years | +95.0% | +81.4% |
| 5 y5 years | +95.0% | +81.4% |
KYTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.0% | at high | +328.1% |
| 5 y | 5-year | at high | +95.0% | at high | +328.1% |
| alltime | all time | at high | +95.0% | at high | +328.1% |
Kyverna Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $38.77 M(+16.0%) |
| Jun 2024 | - | $33.44 M(+13.9%) |
| Mar 2024 | - | $29.36 M(+37.3%) |
| Dec 2023 | $62.41 M | $21.38 M(+31.3%) |
| Sep 2023 | - | $16.28 M(+22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $13.30 M(+16.2%) |
| Mar 2023 | - | $11.45 M(+26.4%) |
| Dec 2022 | $36.41 M(+13.8%) | - |
| Dec 2022 | - | $9.06 M |
| Dec 2021 | $32.00 M | - |
FAQ
- What is Kyverna Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual operating expenses year-on-year change?
- What is Kyverna Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly operating expenses year-on-year change?
What is Kyverna Therapeutics annual total operating expenses?
The current annual operating expenses of KYTX is $62.41 M
What is the all time high annual operating expenses for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual total operating expenses is $62.41 M
What is Kyverna Therapeutics annual operating expenses year-on-year change?
Over the past year, KYTX annual total operating expenses has changed by +$26.00 M (+71.40%)
What is Kyverna Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of KYTX is $38.77 M
What is the all time high quarterly operating expenses for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly total operating expenses is $38.77 M
What is Kyverna Therapeutics quarterly operating expenses year-on-year change?
Over the past year, KYTX quarterly total operating expenses has changed by +$17.39 M (+81.36%)